Dynamic Gait Index As a Functional Gait Assessment Measure in Children with JIA

Last updated: March 5, 2025
Sponsor: Istanbul University - Cerrahpasa
Overall Status: Active - Recruiting

Phase

N/A

Condition

Lupus

Connective Tissue Diseases

Rheumatoid Arthritis (Pediatric)

Treatment

Physical examination

Dynamic Gait Index

Clinical Study ID

NCT06870045
dyi_jia
  • Ages 8-16
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Juvenile idiopathic arthritis (JIA) is one of the most common chronic rheumatic diseases seen in childhood. Pain, joint swelling and loss of function caused by inflammation significantly reduce the patients' quality of life and lead to muscle weakness, limited range of motion and gait disorders. Although there are various clinical assessment methods, there is no functional test in the current literature that evaluates walking in children with JIA.

The Dynamic Gait Index (DGI) is a functional walking scale that evaluates walking on level ground, walking while changing speed, walking with sideways head turns, walking with vertical head turns, walking with pivot turns, walking by jumping over obstacles, going around obstacles and climbing stairs. While the DGA is widely used in the clinical assessment of walking in older adults and other pediatric patient groups, it has not yet been investigated for the assessment of walking difficulties in children with JIA. This study aimed to determine whether the DYI is a usable tool for assessing walking in children with JIA.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Study Group;

  • Having a JIA diagnosis according to ILAR criteria between the ages of 8-16,

  • Having unilateral knee joint involvement that will affect walking

  • Being compatible, volunteer and cooperative in the study Control Group;

  1. Not having any neurological or orthopedic diagnosis

  2. Being between the ages of 8-16

  3. Being at a mental level that can understand the commands of the personperforming the evaluation

Exclusion

Exclusion Criteria:

  • Study Group;

  • Having an additional neurological or orthopedic diagnosis accompanying JIA andaffecting treatment results,

  • Having lower extremity asymmetry or active lower extremity involvement other thanthe knee joint that will affect walking.

Control Group;

-Having any health problem that may affect the study

Study Design

Total Participants: 52
Treatment Group(s): 2
Primary Treatment: Physical examination
Phase:
Study Start date:
February 01, 2025
Estimated Completion Date:
September 30, 2025

Connect with a study center

  • Istanbul University-Cerrahpasa

    Istanbul, 34862
    Turkey

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.